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A B S T R A C T  
The distribution of immune complexes has been studied in mouse spleen 
stimulated to contain many germinal centers (GC's). Horseradish peroxidase 
(HRP)-anti-HRP complexes were used as an appropriately precise and sensitive 
model. We were primarily interested in the relative abilities of three cell types to 
interact with complexes: lymphocytes, macrophages, and follicular dendritic cells 
(FDC's). The latter are distinctive, nonendocytic, stellate cells located primarily 
at the transition of mantle and GC zones of 2 ~ lymphoid follicles (Chen, L. L., J. 
C. Adams, and R. M. Steinman, 1978, J. Cell Biol. 77"148). 
Binding of immune complexes to lymphocytes could not be visualized in situ. 
Macrophages avidly interiorized complexes into lysosomes, but did not retain 
them extracellularly. In contrast, FDC's could retain HRP-anti-HRP extracellu- 
lady under appropriate conditions, but did not endocytose them. Cytochemical 
reactivity accumulated progressively on FDC's 1-6 h after administration of 
complexes i.v., remained stable in amount and location for 1 day, and then was 
progressively lost over a 1- to 5-day period. 
Several variables in the association of complexes with macrophages and FDC's 
were pursued. Only 1 /~g of complexed HRP had to be administered to visualize 
binding to both cell types. Macrophages interiorized complexes formed in a wide 
range of HRP/anti-HRP ratios, while FDC's associated with complexes formed in 
HRP excess only. Quantitative studies with [12SI]HRP-anti-HRP demonstrated 
that 20% of the splenic load of HRP associated with FDC's. Complexes formed 
with an F(ab')~ anti-HRP were distributed primarily in macrophages. When the 
levels of the third component of serum complement were depleted by prior treat- 
ment with cobra venom factor, uptake of complexes by macrophages was reduced 
some 50% whereas association with FDC's was abolished. 
The fact that antigen excess complexes are retained extracellularly strengthens 
the idea that they are immunogenic. Finally, the association of complexes with 
FDC's seems to retard the entry of antigen into the GC proper. 
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Complexes of antigen and antibody may function 
in many ways in the physiology of lymphoid 
organs. Several phenomena have been studied 
and, in each, cellular mechanisms proposed. The 
first studies centered on the ability of antibody to 
clear antigens from the blood stream, primarily 
because phagocytic cells recognize and ingest the 
complexes (3, 45). Then it was established that 
antibody can specifically inhibit the immune re- 
sponse to the subsequent administration of its 
antigen (42; reviewed in reference 43). Simple 
clearance of the antigen does not seem responsible 
(5). Antibody may inhibit by interacting directly 
with the responding B lymphocyte (11), or some 
other nonlymphoid, accessory cell (1). Immune 
complexes may also exert nonspecific, immuno- 
suppressive effects (24, 30), possibly by a direct 
action on B lymphocytes (30). Finally, immune 
complexes can elicit specific responses, especially 
immunologic memory, i.e., the ability of a host to 
respond in an enhanced fashion to a second 
exposure to antigen (15, 20, 40). The following 
sequence of events is envisaged (reviewed in ref- 
erence 41): special dendritic cells ("dendritic mac- 
rophages," "dendritic reticular cells") bind the 
complexes extracellularly (26, 27, 46); the latter 
then stimulate lymphocytes, inducing the forma- 
tion of germinal centers (GC's); these regions of 
proliferating lymphocytes then give rise to mem- 
ory cells. In spite of its potential importance, there 
has been little direct, detailed, or recent work on 
the distribution of immune complexes in lymphoid 
organs, particularly in relation to the proposed 
function of complexes in GC and memory devel- 
opment. 
We recently reported on the anatomy of the 
GC region or 2 ~ follicle ~ (7). This region contains 
at least three different groups of cells distinguish- 
able by cytologic criteria: lymphocytes, both large 
and small (which from previous work, must be 
primarily B cells [17, 25, 31, 39]), macrophages 
and unusual follicular dendritic cells (FDC's). The 
latter are found primarily in the transition region 
between the mantle and GC, and appear to de- 
1The term secondary follicle is used to describe the 
composite of the GC of enlarged, proliferating lympho- 
cytes, and its surrounding "mantle" or "corona" of 
primarily, small, nonproliferating lymphocytes. 
velop in relatively large numbers during the for- 
mation of the GC. FDC's are stellate in shape, 
and their cytoplasmic processes insinuate between 
and even around most of the other cells. FDC's  
are not typical macrophages in appearance or in 
ability to endocytose test particulates. We of 
course wondered whether these FDC's could re- 
tain immune complexes. Alternatively, both lym- 
phocytes and macrophages are capable of binding 
immune complexes (4), and these cells are adja- 
cent to FDC's  in situ. 
In this study, we look at the distribution of 
horseradish peroxidase (HRP)-anti-HRP immune 
complexes in mouse spleen, stimulated by sheep 
erythrocytes to generate many 2 ~ follicles. We 
reasoned that a precise and sensitive EM marker, 
in this case the cytochemical reactivity of HRP, 
was needed to detect and dissect the contributions 
of different cell types in the binding of immune 
complexes in situ. In addition, we have been able 
to study some contributions of antibody, antibody/ 
antigen ratios, and serum complement in the 
distribution of HRP-anti-HRP complexes. 
MATERIALS AND METHODS 
Mice 
Conventionally reared, outbred Swiss mice were ob- 
tained from The Rockefeller University colony and were 
used in most experiments. Inbred DBA/2J (Jackson 
Laboratories, Bar Harbor, Me.), CD2F1 (Flow Labora- 
tories, Dublin, Va.), and outbred, specific pathogen-free 
CD-1 (Charles River Breeding Laboratories, Wilming- 
ton, Mass.) mice were also examined. Mice of both 
sexes, weighing 20-30 g, and 8 wk to 8 mo in age were 
used. 
Preparation o f  Tissue Specimens 
Spleens were processed as previously described (7). 
Briefly, the spleens were fixed by perfusing glutaralde- 
hyde retrogradely through the portal vein. 100- to 200- 
tzm tissue chopper sections were rinsed overnight in 
buffer and then stained successively with diaminobenzi- 
dine tetrahydroehloride and H2Oz (DAB-HzO2) for 1 h 
at room temperature (14), 1% osmium tetroxide for 1 h 
on ice, and 0.25% uranyl acetate for 11/2 h at room 
temperature. The slices were dehydrated and flat- 
embedded in Epon. This technique provided large areas 
of well-fixed and well-penetrated tissue in which the 
various regions of spleen were readily recognized. 
Horseradish Peroxidase 
Sigma Type II enzyme (Sigma Chemical Co., St. 
Louis, Mo.) was used throughout. In some cases, the 
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HRP was radioiodinated (1 p.Ci/mg) with Na-l~zI using 
lactoperoxidase as previously described (32). 
Anti-HRP 
Antisera were raised in rabbits using 10 mg of HRP 
emulsified in Freund's adjuvant, followed by booster 
injections of 1-10 mg of soluble enzyme. In most cases, 
whole, heat-inactivated (56~ I/2 h), Millipore-filtered 
antisera (Millipore Corp., Bedford, Mass.) were used to 
form immune complexes and to immunize passively. The 
whole anti-HRP serum gave results similar to those with 
antisera that had been (a) centrifuged at 80,000 g for 6 
h to remove aggregates, (b) precipitated with 40% 
ammonium sulfate to yield a crude Ig fraction, or (c) 
further purified by Sephadex G-200 chromatography to 
yield a homogeneous, 156,000 mol wt peak (48). An 
F(ab')~ fragment of anti-HRP was prepared by pepsin 
digestion in 0.1 M sodium acetate buffer, pH 4.5, for 
20 h at 37~ followed by isolation of the symmetrical 
106,000 mol wt peak on Sephadex G-200 columns. No 
complement fixation was detectable at the highest dose 
of HRP-F(ab')2 anti-HRP complexes tested, which was 
100 times the dose of complexes formed with intact anti- 
HRP that produced detectable fixation. 
Immune Complexes 
Complexes were formed in the test tube by incubating 
HRP and anti-HRP overnight. The ratio of antigen and 
antibody relative to the equivalence point was deter- 
mined by precipitation as previously described (33), or 
by immunodiffusion using serial twofold dilutions of 
antigen (where equivalence is defined as the ratio at 
which the precipitin line was sharpest). 0.8-200 /xg of 
HRP mixed in varying ratios to anti-HRP were injected 
i.v. In most cases, complexes were given to mice without 
any further separation on the basis of size. In some 
experiments, however, we separated complexes formed 
at twofold antigen excess into three size classes: precipi- 
tates sedimenting at 600 g for 10 min (36% of total 
HRP), precipitates sedimenting at 134,000 g for 30 rain 
(15% of total HRP), and the supemate (49% of total 
HRP). 
Mice were also passively immunized with 0.1-0.5 ml 
of an anti-HRP serum that precipitated an equal volume 
of HRP 400/zg/ml, to equivalence. 24 h later, 10-100 
/xg HRP was given i.v. to form complexes in situ. 
Complement Studies 
Complement fixation in vitro was assessed using 
guinea pig complement (Cordis Laboratories Inc., 
Miami, Fla.) in a standard hemolytic assay (48). Serum 
complement in situ was depleted to <5% of control 
levels by treating mice with Cobra venom factor (CVF; 
Cordis Laboratories Inc., Miami, Fla.), 6 U i.v. at 8-h 
intervals over 24 h. Serum C3 levels were measured by 
radial immunodiffusion (10), using a sheep anti-mouse 
C3 generously provided by Dr. Celso Bianco (State 
University of New York, Brooklyn, N. Y.). 
Experimental Plan 
GC's were furst induced in spleen by the injection of 2 
• 10 s sheep erythrocytes i.v. or i.p. 6-14 days before 
study. HRP-anti-HRP complexes were administered i.v. 
6-24 h before sacrifice, in most cases. Enzyme was then 
visualized cytochemically at light and EM levels. In some 
experiments, [I~I]HRP was used. Then the amount of 
radioactivity was measured in a gamma scintillation 
counter (Packard Instrument Co., Inc., Downers Grove, 
Ill.) either in whole spleen or after dissection of specific 
regions of spleen- red pulp, 2 ~ follicle, and other white 
pulp. The rationale of the dissection approach will be 
explained (see Results). 
RESULTS 
Distribution o f  Soluble HRP 
We were able to visualize exogenous, soluble 
HR P  in spleen cells only after the administration 
of large doses of enzyme (1 mg or more). As 
described previously (7), 1 h after i.v. HRP,  
granules of reaction product were seen primarily 
in macrophages, especially in the marginal zone 
and red pulp regions (Fig. 1). Granules were also 
scattered in smaller numbers  throughout the white 
pulp, including the GC's  when these were present 
(Fig. 1). By EM,  reaction product was evident 
within intracellular vacuoles of typical macro- 
phages, and also in lymphocytes of the white pulp 
(Fig. 2). No extracellular HR P  was evident on any 
of the cell types, including FDC's.  24 h later, 
cytocbemical reaction product due to exogenous 
enzyme had entirely disappeared. 
Cell Types Involved in the Retention 
o f  Preformed Complexes o f  
HRP-Anti-HRP: Cytochemical Analysis 
Immune complexes were retained in a dramati- 
cally different fashion than soluble enzyme with 
respect to efficiency of capture, fate, and distribu- 
tion. Thus, microgram amounts of complexed 
HRP were readily visualized, 24 h or more after 
injection, and in different locations. The most 
interesting situation will be considered first, i.e., 
mice primed 6-12 days with sheep erythrocyte to 
form many GC's  and then challenged with com- 
plexes formed in slight antigen excess (two- to 
fourfold). 
Reaction product of HRP-excess complexes was 
found in two locations. One  was the marginal 
zone-red pulp area, where collections of reactive 
granules were noted by LM (Fig. 3). By EM,  the 
granules proved to be lysosomes in typical macro- 
phages. Connective tissue cells in the marginal 
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FIGURE 1 Light micrograph of the 2 ~ follicle region 1 h after the administration of 3 mg of HRP i.v. 
Endogenous peroxidatic reactivity is noted in erythrocytes (R) in the red pulp sinuses, and in granulocytes 
(not shown here). Exogenous (HRP) reactivity is distributed as granules, mainly in macrophages (M), but 
also scattered throughout the mantle and germinal center regions (e.g. arrows). Follicular dendritic cells 
(F) are identified by large nuclei which lack heterochromatin, x 910. 
FIGURE 2 Electron micrograph of the mantle region from the spleen shown in Fig. 1. Reaction product 
is found in lymphocyte lysosomes (short arrows) and occasionally in FDC processes (long arrow). No 
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FIGURE 3 Light micrograph of the 2 ~ follicle in a mouse 24 h after injection of HRP-anti-HRP immune 
complexes. The antioHRP was a 156,000 mol wt, sephadex G200 cut of a rabbit antiserum; the complexes 
were formed in twofold antigen excess; and 27/xg of HRP was given i.v. Reaction product is seen in two 
locations and patterns. One is the marginal zone and red pulp where macrophages (M) have collections of 
granules. Connective tissue cells (CT) here and elsewhere are negative. HRP is also seen at the mantle- 
GC interface, primarily as thin streaks (arrows) which prove to be extracellular on FDCs (F). Some 
mantle macrophages (M) have granules of reactivity. Reactivity is sparse or absent deeper in the GC, 
either on FDC's (F) or in tingible body macrophages (TBM). Probably, complexes do not penetrate into 
this region. • 1130. 
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FI6URE 4 Low power EM of a mantle-GC transition region. This specimen was stained en bloc with 
DAB-H2Oe and uranyl acetate, but the sections were not stained with heavy metals. Cytochemical 
reaction product is distributed exclusively on cell processes of FDC's (arrows), "lighting up" the intricate 
and convoluted network which these cells form in the mantle zone. Some macrophages (Mac t to Mac 2) 
have endocytosed complexes, but others (Mac 3) show little reactivity. Reaction product is not found on 
the macrophage surface, or associated with lymphocytes, small (SL) or large (LL). • 3,800. 
zone and red pulp, which endocytose markers 
such as soluble H R P ,  colloidal carbon, and thor- 
ium dioxide (7), did not take up immune com- 
plexes (Fig. 3). The other  region with cytochemi- 
cal reactivity was the mantle-CJC interface, where 
streaks of reaction product were seen (Fig. 3). By 
EM,  most of this reaction product was clearly 
extracellular on fine cell processes (Figs. 4-6) .  
These processes arose almost entirely from FDC ' s  
(7), and in this study we noted that the FDC was 
the only cell body with extracellular enzyme (Fig. 
5). The thickness of extracellular reactivity varied 
depending on the dose of complexes injected and 
on the time the mouse was sacrificed, but, at all 
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FIGtJm~S 5 and 6 Higher powers of the distribution of reaction product in mice given complexes in 
antigen excess. The material was stained en bloc only. In Fig. 5 (x 6,200), the FDC proves to be the only 
cell body showing extraceIIular stain. However, little endocytosis of HRP, e.g., in the Golgi region 
(arrow), is evident. In Fig. 6 (• 9,000), reactive FDC processes (arrowhead) are found near a tingible 
body macrophage in the mantle. This macrophage has intracellular enzyme. Even the tingible bodies (T) 
are reactive, but the cell surface (long arrows) is negative. Most tingible bodies, especially those deep in 
the GC, are negative, however. 
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times, labeled intraceUular vacuoles in FDC's 
were rare. Some macrophages in the mantle con- 
tained reactive granules (Figs. 4 and 6), while 
others were negative (Fig. 4), even though they 
were adjacent to reactive FDC processes. Macro- 
phages lacked surface staining. Binding and/or 
uptake of enzyme by lymphocytes was not clearly 
evident, although reactive FDC processes were 
usually adjacent to the lymphocyte surface. Extra- 
cellular enzyme on FDC processes was seen only 
in the GC region of spleen, and was evident in all 
GC's. 
Complexes in antibody excess (two- to fourfold 
by weight) were also retained efficiently, i.e., 
microgram doses of enzyme produced abundant 
cytochemical reaction product. However, staining 
was entirely confined to macrophages in the red 
pulp, marginal zone, and to a lesser extent, white 
pulp (Figs. 7 and 8). Extracellular enzyme on 
FDC's was totally lacking even though the anat- 
omy of the follicle region was similar to that in 
mice retaining antigen excess complexes. Com- 
plexes formed at equivalence were found only in 
small amounts extracellularly and were abundant 
in macrophages. Complexes formed in 10-fold 
antigen excess were not retained in a sufficient 
extent to be visualized cytochemically. 
Distribution of  Preformed 
[I~ZI]HRP-Anti-HRP Complexes: 
Quantitative Studies 
A dissection approach was devised to measure 
the amount of HRP present in regions of spleen 
rich in macrophages (red pulp-marginal zone) vs. 
FDC's (mantle-GC interface in 2 ~ follicles). 
[~zSI]HRP was included in the immune complexes, 
and then cytochemistry was applied to tissue chop- 
per slices to delineate various regions of the 
spleen. When slices were stained with DAB- 
H20~, endogenous peroxidatic activity (erythro- 
cyte) clearly distinguished red from white pulp 
(Fig. 9). In addition, slices from animals given 
complexes in two- to fourfold antigen excess had 
readily detectable "smiles" of reaction product in 
the white pulp nodules (Fig. 9a). Smiles were 
lacking in animals given complexes in antibody 
excess, or soluble enzyme (Fig. 9 b). By micro- 
scope analysis, the smiles represented HRP in the 
mantle-GC region, which was predominantly ex- 
tracellular on FDC's (Figs. 3-6). So we could then 
dissect out pieces of white pulp containing smiles 
and compare them to the remainder of white and 
red pulp. 
18-24 h after administration of complexes in 
antigen excess, 0.05-0.20% of the injected HRP 
was recovered in spleen and 5-8% in liver. ~zI 
counts/mg tissue (specific activity) was highest in 
the smile region (Table I). Because the smile 
accounted for only a part of the dissected area, 
the specific activity actually was much higher. Red 
pulp-marginal zone pieces also had high levels of 
radioactivity (similar to that seen in liver pieces), 
but the remaining white pulp had few counts. 
To obtain a measure of total [~ I ]HRP in 
various regions of spleen, we first considered 
white pulp counts to be background, because 
HRP was not visualized in white pulp aside from 
the mant~'-GC interface. All areas of white pulp 
with smiles were dissected out from a large pro- 
portion of spleen slices. This amount of radioactiv- 
ity was subtracted from that in whole spleen slices 
to give the percentage of radioactivity in red pulp- 
marginal zone. Some 20 and 80%, respectively, 
of the splenic load of HRP was then found to be 
associated with FDC's (smiles) and macrophages 
(red pulp-marginal zone), respectively (Table I). 
Kinetics of Accumulation and Loss 
of  lmmune Complexes 
The distribution of two times antigen excess 
complexes was examined by cytochemistry at 
varying times after administration of a single dose 
(48 /~g HRP) i.v. At 1 h, enzyme was found in 
macrophages. The amount of cytochemical reac- 
tion product was similar to that observed over the 
subsequent 24 h. Extracellular HRP was rare at 1 
h. At 2 h, extracellular enzyme became detecta- 
ble, but selectively, on FDC's. FDC staining then 
increased steadily at 4 and 6 h, changed little over 
the remainder of the 1st day, and then was 
progressively lost over the next 2-5 days. Macro- 
phage staining was also lost over this time period. 
If anything, reactivity was noted at later intervals 
in some mantle macrophages. Conceivably, the 
latter slowly cleared the FDC surface by phagocy- 
tosis. 
Although clearly extracellular, complexes asso- 
ciated with FDC's appeared unable to move freely 
throughout the 2 ~ follicle. At early time points, 
many macrophages in the mantle near FDC's 
lacked detectable enzyme. At later times, little 
intra- or extracellular HRP was noted in the bulk 
of the GC even though FDC's and macrophages 
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FIGURES 7 and 8 Light (x 890) and electron (• 4,600) micrographs 24 h after injection of 20 p,g of 
HRP in fourfold antibody excess. Red pulp and marginal zone macrophages (M) are full of reactive 
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FIGURE 9 DAB-stained, tissue chopper slices of spleen from mice given complexes in (a) antigen excess 
(x 172) and (b) antibody excess (x 172). In both, endogenous, erythrocyte peroxidatic activity stains the 
red pulp while the white pulp nodules are clear except for dots of reactivity in blood vessels. In Fig. 9a, a 
smile of reaction product (arrow) is seen which corresponds to the network of stained FDC processes at 
the mantle-GC interface (Figs. 3-6). The perimeter of the GC is therefore outlined on its mantle aspect, 
permitting dissection of the GC or entire 2 ~ follicle for further study. 
(tingible body macrophages) were present (Fig. 
3). 
Distribution o f  HRP in Passively 
Immunized Mice 
Preloading the mouse with rabbit anti-HRP, in 
this case by passive immunization, led to a dra- 
matic increase in the ability of spleen to retain a 
subsequent injection of soluble HRP, as has been 
documented in other studies (21, 36). These mice 
contained enzyme both in macrophages and on 
FDC's, as occurs in mice given preformed com- 
plexes in antigen excess. 
Other Factors in the Retention 
o f  Immune Complexes 
Extracellular HRP was detected over the full 
dose range studied (0.8-200 p.g of HRP com- 
plexed in antigen excess). The number of stained 
FDC processes, as well as the amount of stain per 
process, increased with increasing doses. 
Large precipitates of Ag excess complexes (sed- 
imenting at 600 g for 10 min) localized predomi- 
nantly in macrophages in spleen. Smaller aggre- 
gates (sedimenting at 134,000 g for 300 min) 
were retained extracellularly on FDC's primarily. 
The soluble component in the preparation of 
antigen excess complexes (i.e., not sedimenting at 
134,000 g for 300 min) was not detectable at the 
doses used, 165/xg of HRP. 
Complexes formed with an F(ab')z anti-HRP in 
two times HRP excess were also retained. The 
dose of complexes had to be increased 5- to 10- 
fold over complexes formed with intact anti-HRP 
to achieve comparable levels of cytochemical reac- 
tivity. Most of the reaction product in F(ab')2 
complexes was present in macrophages, including 
those in the mantle region (Fig. 10). By EM, 
surface staining of FDC's was still detectable, 
however (Fig. 11). 
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TABLE I 
Distribution of I12~I]HRP-Anti-HRP Complexes in 
Spleen 
Region of spleen Exp 1 Exp 2 Exp 3 
sp act (~1 cpm/mg dry weight) 
Whole spleen 401 147 159 
Mantle-GC interface* 621 308 249 
White pulpit 77 30 24 




To~ acnv~ (% ~ 1  cpm m ~&en) 
78 83 79 
22 17 21 
[lzSI]HRP complexes in twofold HRP excess were in- 
jected into individual mice 24 h (Exp 1) and 18 h (Exp 
2 and 3) before sacrifice. Spleens were perfusion-fixed, 
and tissue chopper slices were stained with DAB-H202. 
Specific regions of the spleen were first dissected out 
(see Results and Fig. 9) with 21-26 gauge hypodermic 
needles, washed extensively to remove soluble radioac- 
tivity, and then groups of 50-100 pieces were assayed 
for radioactivity/dry weight. To determine total activity 
in red pulp-marginal zone vs. mantle-GC interface, we 
first considered the value for white pulp as background. 
We then obtained a value for total activity in a large 
sample of smiles and subtracted this from whole spleen 
data to obtain a value for red pulp-marginal zone. 
* Mantle-GC interface: This is the region identified as a 
smile on tissue chopper sections (Fig. 9 a) and containing 
predominantly extracellular HRP or FDC's. 
~t White pulp: This is the middle of the nodule without 
any smile and without any cytochemical reaction product 
by microscopy. 
Studies on the Role o f  
Serum Complement 
Mice containing GC's were treated with CVF to 
decrease serum C3 levels to <5% of control 
values. This treatment did not alter the anatomy 
of the follicular region, particularly the FDC's. 
However, antigen excess complexes formed with 
intact or with F(ab')z anti-HRP were now visual- 
ized only in macrophages, and not extracellularly 
on FDC's. 
To gain some idea of the clearance and total 
amount of HRP reaching the spleen, in CVF 
mice, the organ distribution of [I~I]HRP anti- 
HRP complexes in twofold HRP excess was fol- 
lowed in two control and three CVF mice (these 
controls behaved like several others in independ- 
ent experiments). Complexes were cleared rapidly 
from the circulation in both groups (Table II) 
although a little more rapidly in CVF mice. Liver 
uptake was increased slightly after CVF treat- 
ment, and splenic uptake was reduced to 30-40% 
of control (Table II). 
Because complement appeared to be required 
for FDC retention, we compared the ability of 
complexes formed at varying HRP/anti-HRP ra- 
tios to fLX guinea pig complement in the test tube 
by a hemolytic assay. All complexes fixed comple- 
ment similarly in vitro even though complexes in 
antigen excess preferentially associated with 
FDC's in situ. We conclude that complement 
fixation alone may be insufficient to mediate 
binding of FDC's. Some additional step must 
occur (see Discussion). 
DISCUSSION 
H R P  as a Model Antigen 
The glycoprotein enzyme, HRP, has several 
advantages as a model for studying the distribu- 
tion of antigenic materials in lymphoid organs. 
Both antigen (HRP) and antibody are readily 
available. The enzyme can be visualized cyto- 
chemically at LM and EM levels. The technique 
(14) can be applied to aldehyde-fixed tissue, so 
that the complex microanatomy of lymphoid or- 
gans is maintained. Precision is gained from the 
fact that the highly insoluble reaction product 
appears to be deposited very close to the enzyme's 
active site. Sensitivity is indicated by the fact that 
we readily visualized HRP in spleen when we 
injected <1 /~g of complexed enzyme i.v., under 
conditions in which only 0.2% of the injected 
antigen was present in the entire spleen. 
The need for a precise and sensitive marker 
such as HRP became evident after several devel- 
opments that occurred after the initial work on 
antigen retention in lymphoid organs. First, it is 
now known that B lymphocytes bind immune 
complexes (4, 12), and it has also been suggested 
that typical phagocytic cells can both ingest and 
retain antigens extraeeUularly (44). Both B lym- 
phocytes and macrophages are present in lymph- 
oid follicles, so that their potential contribution to 
antigen retention must be considered. In addition, 
the complex microanatomy of the 2 ~ follicle was 
not outlined in earlier work, especially the unique 
cytologic features of FDC's. These cells send out 
fine cell processes that make contact with most 
other cells (lymphocytes and macrophages) in the 
follicle, especially at the mantle-GC interface (7). 
Given these developments, a marker such as HRP 
is required to decide: whether antigen is intra- or 
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FI~trRES 10 and 11 Light (• 1,210) and electron (• 4,100) micrographs after injection of 40/~g of 
HRP as a twofold antigen-excess complex formed with an F(ab')2 anti-HRP. In Fig. 10, extensive uptake 
by macrophages (M) in both mantle and marginal zone is evident. Extracellular staining is barely 
detectable by LM, though by EM (Fig. 11 ) it is evident (arrows) exclusively on FI)C's. Granulocytes (G) 
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TABLE II 
Organ Distribution of p~I]HRP-anti.HRP after CVF Treatment 
Control CVF-Treated 
Organ Mouse 1 Mouse 2 Mouse 1 Mouse 2 Mouse 3 
Total cpm/organ (• 10 z) 
Blood (50 p.1) 
1 h 21.3 25.8 15.7 18.9 8.47 
3 h 8.61 13.7 4.34 4.89 3.10 
5 h 3.24 4.24 2.54 2.72 2.34 
Liver 363 368 477 467 489 
Spleen 15.6 16.1 7.57 7.73 6.29 
Lung 11.0 6.66 5.75 4.18 4.39 
6 x 106 cpm of [:~I]HRP in a twofold antigen excess complex was injected i.v. into two control and three mice 
treated previously with CVF, to reduce serum C3 levels to <5% of control. At 1, 3, and 5 h, 50-~I blood samples 
were taken, and at 6 h the mice were sacrificed. Total cpm is presented for liver, spleen, and lung. The average 
weight of liver, spleen, and lung was 1.6, 0.14, and 0.22 g. 55-65% of the counts were precipitable in 10% TCA. 
extracellular, what cell types are involved in anti- 
gen binding, and whether the marker is truly 
associated with the surface of a particular cell or 
simply distributed at random in the extracellular 
space. 
The attributes of HRP cytochemistry were not 
available at the time of previous studies on the 
distribution of antigens. Immunofluorescence has 
been used to localize antigens (45, 46), but the 
material consisted of relatively thick sections. Au- 
toradiography, primarily at the light level, has also 
been used, especially with radioiodinated antigens 
(27). This approach is simply not precise enough 
for establishing the cellular distribution of small 
amounts of antigen. EM autoradiography of 1251- 
tagged antigens was attempted to gain increased 
resolution (26, 38), but then large doses of radio- 
iodinated antigens and/or heavily substituted ma- 
terials were required, further complicating the 
interpretation of the observations. 
Another potential advantage of HRP, not really 
utilized in this study, is that this enzyme is capable 
of actively inducing immune responses in which 
the specific antibody-forming cells can be visual- 
ized (2). In this paper, we have looked at the 
distribution of immune complexes formed in vitro 
or after passive immunization in situ. It remains to 
be seen whether our observations can be extended 
to mice undergoing an active immune response to 
HRP. 
Cell Types Involved in 
H R P  Retention 
Most cell types in lymphoid organs could inter- 
act with HRP, depending on the form and amount 
of enzyme administered. After large doses (milli- 
grams) of soluble enzyme, lymphocytes both large 
and small showed reactive intracellular granules 
which had to be derived by endocytosis of HRP in 
the extracellular space. HRP has a small molecu- 
lar weight (40,000) and is rapidly cleared from 
circulation, especially by glomerular filtration 
(37). Possibly, endocytosis of lower doses of HRP 
would have been detectable had the life span of 
circulating enzyme been longer. It is unclear to 
what extent other soluble protein antigens might 
be pinocytosed the same as HRP. If HRP is 
interiorized in the content of the fluid phase, then 
all other proteins might be expected to be included 
in lymphocyte endocytic vacuoles. Alternatively, 
HRP might have been interiorized by a more 
selective, adsorptive pathway. 
Lymphocytes did not retain significant amounts 
of HRP-anti-HRP immune complexes either on 
the cell surface or intracellularly, at the doses 
used. Conceivably, complexes did interact with 
lymphocytes, either in spleen or in the circulation, 
but were then eluted from the surface before the 
time we fixed the spleens. For example, it is 
evident that certain immune complexes can be 
removed from lymphocytes by a process that 
requires activation of serum C3 (22). 
Macrophages, i.e., mononuclear cells with a 
well-developed vacuolar system including abun- 
dant lysosomes, actively interiorized HRP admin- 
istered either as soluble or complexed enzyme. 
Much lower doses of immune complexed HRP 
had to be given to detect uptake (several hundred- 
fold), and complexed enzyme persisted intracellu- 
lady for longer periods. Persistence or retention 
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of soluble and complexed HRP on the macro- 
phage surface was not detectable. All these find- 
ings are identical to those previously documented 
in tissue culture of mouse peritoneal macrophages 
(32, 33). We therefore presume that the mecha- 
nism of uptake in situ is similar to that occurring 
in vitro, i.e., soluble enzyme is interiorized in the 
fluid phase of pinocytic droplets, and immune 
complexes are found and interiorized via recogni- 
tion sites for the F~ region, and/or affixed C3. 
The cell type of most interest was the FDC. 
These cells were previously shown to be nonen- 
docytic cells, by the use of nonimmunogenic par- 
ticulate tracers (7). Both colloidal carbon and 
thorium dioxide particles associated selectively 
with the FDC surface (7), and in this study 
immune complexes behaved similarly. A critical 
range of antigen to antibody had to be used, that 
is, two- to fourfold antigen excess, before com- 
plexes associated with FDC's, but under no cir- 
cumstances was active endocytosis evident. With 
antigen excess complexes, the concentration of 
HRP in the FDC-rich areas of spleen was proba- 
bly greater than in any other. We do not know 
how long active antigen (vs. enzyme) can remain 
in association with FDC's. At the doses used, 
extracellular enzyme activity was progressively 
lost over a 3- to 6-day period. 
Our observations demonstrate the clear-cut dif- 
ferences between FDC's and macrophages. 
FDC's, which do not look like endocytic cells, 
retain complexes on their surface and do not 
endocytose them; the reverse is true for macro- 
phages. No transitional or intermediate forms 
were evident. Although the nomenclature and 
literature are confusing on this point, cells that are 
variously referred to as "reticular" cells or macro- 
phages probably represent many different cyto- 
logic and functional entities. 
Mechanism o f  Immune Complex 
Retention on FDC's 
Antigen excess complexes associated similarly 
with FDC's in all GC's, whether elicited by the 
non-cross-reacting antigen, sheep erythrocyte, or 
by endogenous stimuli in the environment of 
certain batches of mice. Thus, the activity of 
FDC's seems to be selective for complexes rather 
than the antigen per se, and corresponds to the 
binding of nonimmunogenic particulates docu- 
mented previously (7). We are currently examin- 
ing the cytologic changes that occur during the 
development of GC's, with emphasis on FDC's 
and immune complex retention. Preliminary find- 
ings are that selective binding to similar cells can 
occur before GC formation. 
Two sorts of experiments were attempted to 
find out what components of an immune complex 
were responsible for binding to FDC's. Earlier 
workers emphasized the requirement for specific 
antibody, probably the F~ portion (16, 19, 21). 
We found that F(ab')2 anti-HRP-HRP complexes 
exhibited greatly reduced association with FDC's. 
We hesitate at this time to conclude that the Fe 
portion of the anti-HRP is critical. Naturally oc- 
curring anti-F(ab')2 antibodies (28, 49) have been 
demonstrated in some species. The presence of 
such reagents in our mice might alter the ratio of 
antibody to antigen in the complex and make it 
behave more like a complex in antibody excess. 
Recent work has focused on the function of 
serum complement components, especially C3, in 
the phenomenon of antigen retention (18, 29). It 
has been noted that C3 is present in the same sites 
as antibody in cryostat sections stained with an 
anti-C3 reagent (13), and that depletion of serum 
C3 with CVF reduces either GC formation and/or 
antigen retention (29, 47). We found that CVF 
treatment dramatically reduced FDC binding of 
HRP-anti-HRP complexes. 
Complement may operate in several ways, 
though it is not clear that any of those mechanisms 
accounts for the requirement of complexes in 
antigen excess. For example, complement may 
serve to solubilize and/or break down the com- 
plexes to smaller sizes (4, 9). This might enhance 
penetration of complexes into the white pulp and/ 
or retard binding and uptake by macrophages. 
Complement may mediate the interaction of com- 
plexes with other cells, e.g., B lymphocytes (6), 
platelets, and neutrophils (4, 8), which then may 
help deliver and/or alter the complex so that it 
binds to FDC's. Finally, complement may be 
recognized by receptors on the FDC surface. 
However, none of the Fe and C3 receptors that 
function to bind complexes to cell surfaces in vitro 
(e.g., mononuclear phagocytes, lymphocytes, 
platelets) have been shown to mediate the pro- 
longed retention of immune complexes on cell 
surfaces (e.g. reference 23). Also, we think that 
FDC's may arise from a population of dendritic 
cells that we have identified in vitro in mouse 
spleen suspensions (34), and these cells do not 
demonstrate receptors for immune complexes 
(35) even after prolonged culture (R. Steinman, 
unpublished observations). 
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Significance o f  I m m u n e  Complexes 
on FDC's  
Ever since it was noted that antigens were 
retained for prolonged periods in the 2 ~ follicle, it 
has been assumed that the retained material has 
some immunogenic functions, e.g., triggering the 
proliferation of lymphocytes in the GC proper. 
This possibility is enhanced by our observation 
that complexes in antigen excess may be prefer- 
entially retained, and that the area in which 
complexes are deposited is the site through which 
most B lymphocytes recirculate (17, 25). Immu- 
nogenicity remains to be established. For exam- 
ple, we would like to know whether one can 
correlate extracellular HRP retention with the 
development of an immune response to HRP. 
Another possible role for FDC binding is that 
the FDC is removing complexes from lympho- 
cytes, and/or preventing them from gaining access 
to the GC. We were struck by the fact that soluble 
HRP within 1 h was endocytosed by GC lympho- 
blasts. Even at 24 h, immune complexes were 
localized at the mantle-GC interface with little 
entry into the GC. Binding of immune complexes 
to lymphocytes may alter their physiologic func- 
tion, e.g., their ability to recirculate through 
lymphoid organs or to respond to antigens. These 
possibilities can be approachod in the HRP-anti- 
HRP system, because the effects of complexes on 
immune responses can be correlated with precise 
information on their distribution in the lymphoid 
organ. 
This work was supported by the National Institutes of 
Health (NIH) grant AI 13013-02. L. L. Chen is an NIH 
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